• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Carotid Artery Disease Market

    ID: MRFR/MED/4840-CR
    157 Pages
    Kinjoll Dey
    July 2019

    Carotid Artery Disease Market Research Report Information by Diagnosis & Treatment (Carotid Artery Disease and Antihypertensive Drugs), End User (Hospital & Clinics, Ambulatory Surgical Centers and Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Carotid Artery Disease Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Carotid Artery Disease Market Summary

    The Global Carotid Artery Disease Market is projected to grow from 12.4 USD Billion in 2024 to 20.7 USD Billion by 2035.

    Key Market Trends & Highlights

    Carotid Artery Disease Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.75 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 20.7 USD Billion, indicating robust growth.
    • In 2024, the market is valued at 12.4 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing prevalence of carotid artery disease is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.4 (USD Billion)
    2035 Market Size 20.7 (USD Billion)
    CAGR (2025-2035) 4.75%

    Major Players

    Medtronic Plc, Pfizer, GE Healthcare, Cardinal Health, Eli Lily and Company, AdvanceCor GmbH, Teleflex, Siemens Healthcare, Daiichi Sankyo Co. Ltd., Abbot Laboratories, Bristol-Myers Squibb, Merck & Cp. Inc., Silk Road Medical, Stryker Corporation, Hitachi, Terumo Corporation, Boston Scientific Corporation, Dickinson Company, L. Gore & Associates, Inc.

    Carotid Artery Disease Market Trends

    The increasing prevalence of carotid artery disease, coupled with advancements in diagnostic and therapeutic technologies, suggests a growing demand for effective management strategies in the healthcare sector.

    Centers for Disease Control and Prevention (CDC)

    Carotid Artery Disease Market Drivers

    Market Growth Projections

    The Global Carotid Artery Disease Market Industry is projected to experience substantial growth in the coming years. With a market value of 12.4 USD Billion in 2024, it is anticipated to reach 20.7 USD Billion by 2035, reflecting a robust CAGR of 4.75% from 2025 to 2035. This growth trajectory indicates a strong demand for innovative treatment options and improved healthcare services aimed at managing carotid artery disease. The increasing investment in research and development, coupled with advancements in medical technology, is likely to drive this market forward, presenting opportunities for stakeholders in the healthcare sector.

    Growing Geriatric Population

    The aging population is a key driver of the Global Carotid Artery Disease Market Industry. As individuals age, the risk of developing carotid artery disease increases, necessitating effective healthcare solutions. By 2035, the market is expected to reach 20.7 USD Billion, largely due to the growing number of elderly individuals who require medical attention for cardiovascular conditions. This demographic shift is prompting healthcare providers to focus on tailored interventions and preventive strategies for older adults, thereby expanding the market. The implications of this trend are profound, as it highlights the need for specialized care in managing carotid artery disease.

    Rising Awareness and Education

    Increased awareness and education regarding cardiovascular health are pivotal in shaping the Global Carotid Artery Disease Market Industry. Public health campaigns and educational programs are effectively informing individuals about the risks associated with carotid artery disease and the importance of regular check-ups. This heightened awareness is likely to lead to earlier diagnoses and increased demand for treatment options. As healthcare providers emphasize the significance of preventive care, the market is expected to grow in response to these educational efforts. The proactive approach towards health management may ultimately reduce the burden of carotid artery disease on healthcare systems.

    Advancements in Medical Technology

    Technological innovations play a crucial role in shaping the Global Carotid Artery Disease Market Industry. The development of minimally invasive surgical techniques and advanced imaging modalities has revolutionized the diagnosis and treatment of carotid artery disease. For instance, the introduction of carotid artery stenting and improved ultrasound technology has enhanced patient outcomes and reduced recovery times. As these technologies become more widely adopted, they are likely to contribute to market growth. The anticipated CAGR of 4.75% from 2025 to 2035 further underscores the potential for continued advancements in medical technology to drive the industry forward.

    Government Initiatives and Funding

    Government initiatives aimed at improving cardiovascular health are significantly influencing the Global Carotid Artery Disease Market Industry. Various health organizations and government bodies are implementing programs to raise awareness about carotid artery disease and promote preventive measures. Funding for research and development in this field is also increasing, which may lead to the discovery of new treatment options. These initiatives not only enhance public knowledge but also encourage healthcare systems to prioritize the management of carotid artery disease. As a result, the market is likely to benefit from these supportive measures, fostering growth and innovation.

    Increasing Prevalence of Carotid Artery Disease

    The Global Carotid Artery Disease Market Industry is experiencing growth due to the rising prevalence of carotid artery disease, which is often linked to lifestyle factors such as obesity, hypertension, and diabetes. As populations age, the incidence of this condition is expected to rise, leading to an increased demand for diagnostic and therapeutic interventions. In 2024, the market is projected to reach 12.4 USD Billion, reflecting the urgent need for effective management strategies. This trend indicates a growing awareness among healthcare providers and patients alike regarding the importance of early detection and treatment of carotid artery disease.

    Market Segment Insights

    Regional Insights

    Key Companies in the Carotid Artery Disease Market market include

    Industry Developments

      • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
      • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.

    Future Outlook

    Carotid Artery Disease Market Future Outlook

    The Carotid Artery Disease Market is projected to grow at a 4.75% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence, and enhanced healthcare access.

    New opportunities lie in:

    • Develop innovative minimally invasive surgical techniques to improve patient outcomes.
    • Invest in telemedicine solutions for remote monitoring of carotid artery disease patients.
    • Expand partnerships with healthcare providers to enhance patient education and awareness programs.

    By 2035, the Carotid Artery Disease Market is expected to exhibit robust growth, reflecting advancements in treatment and increased patient engagement.

    Market Segmentation

    By Type

    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By Region

    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By End-User

    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Segmentation

    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By Medications

    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Report Overview

    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Recent Developments

    • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.
    • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    By Surgical Procedures

    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Report Score and Segmentation

    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    treatment for carotid artery disease

    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    carotid artery disease and stenosis treatment

    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Carotid Artery Disease Market Competitive Landscape

    • L. Gore & Associates, Inc.
    • Dickinson Company
    • Boston Scientific Corporation
    • Terumo Corporation
    • Hitachi
    • Stryker Corporation
    • Silk Road Medical
    • Merck & Cp. Inc.
    • Bristol-Myers Squibb
    • Abbot Laboratories
    • Daiichi Sankyo Co. Ltd.
    • Teleflex, Siemens Healthcare
    • AdvanceCor GmbH
    • Eli Lily and Company
    • Cardinal Health
    • GE Healthcare
    • Pfizer
    • Medtronic Plc
    • Stryker Corporation in July 2018, renewed the “Pre-Market Approval” (PMA) from the FDA (Food and Drug Administration) of the United States.
    • Boston Scientific Corporation in July 2018, announced the acquisition of Claret Medical Inc.
    • Recent Development
    • Competitive Analysis
    • Regional Analysis
    • Market Segmentation
    • Value Chain Analysis
    • Dynamics of the Market
    • COVID-19 Analysis
    • Market Overview
    • Historical Period -2019-2020
    • Forecast Period - 2021-2028
    • Base Year -2021
    • Study Period - 2021-2028
    • Others
    • Magnetic Resonance Imaging
    • Compound Tomography
    • Duplex Ultrasound
    • Diagnosis
    • Treatment
    • Antihypertensive Drugs
    • Cholesterol-Lowering Statins
    • Antiplatelet Drugs
    • Carotid Endarterectomy
    • Carotid Artery Bypass
    • Carotid Artery Angioplasty
    • Ambulatory Surgical Centres                                  
    • Pharmacies
    • Clinics and Hospitals
    • The Middle east Africa
    • Europe
    • Asia-Pacific
    • Latin America
    • North America

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 11.9 (USD Billion)
    Market Size 2024 12.4 (USD Billion)
    Market Size 2032 17.3 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.1 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Forecast Units Value (USD Billion)
    Segments Covered Type, Application, and End-User
    Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
    Key Vendors Medtronic Plc, Pfizer, GE Healthcare, Cardinal Health, Eli Lilly and Company, AdvanceCor GmbH, Teleflex, Siemens Healthcare, Daiichi Sankyo Co. Ltd., Abbott Laboratories, Bristol-Myers Squibb, Merck & Co. Inc., Silk Road Medical, Stryker Corporation, Hitachi, Terumo Corporation, Boston Scientific Corporation, Dickinson and Company, W. L. Gore & Associates, Inc.
    Key Market Opportunities Increasing government support, rising investments in healthcare, and the presence of a well-established pharmaceutical market
    Key Market Drivers Growing older population, rising cases of life-threatening diseases, and increasing applications of advanced treatment procedures in diagnostics

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    At what CAGR is the carotid artery disease market projected to grow in the forecast period (2024-2032)?

    Carotid artery disease market projected to grow at approximately 6.10% CAGR during the assessment period (2024-2032).

    How much is the carotid artery disease market worth in the future?

    The valuation of the carotid artery disease market is estimated to increase to USD 17.30 BN by the end of 2032.

    What are the major tailwinds pushing the growth of the global carotid artery disease market?

    Rising prevalence and demand for early diagnosis & treatment of the condition are major tailwinds pushing the growth of the global carotid artery disease market.

    Which region holds the largest share in the global carotid artery disease market?

    North America holds the largest share in the global carotid artery disease market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global carotid artery disease market?

    Becton, Dickinson and Company, Hitachi Ltd., W. L. Gore & Associates, Inc., Terumo Corporation, Abbott, Medtronic, Silk Road Medical, Inc., Stryker Corporation, Boston Scientific Corporation, and Cardinal Health, are some of the top players operating in the global carotid artery disease market.

    1. '1 Executive Summary
    2. Market Introduction
      1. Scope of Study
      2. Research Objective 16
      3. List of Assumptions 17
    3. Research
    4. process
      1. Research Process 18
      2. Primary Research 19
      3. Secondary
    5. Research 20
      1. Market Size Estimation 21
    6. Market Dynamics
      1. Introduction
      2. Drivers 22
        1. Increasing Geriatric Population 22
    7. Increasing Adoption of Unhealthy Lifestyle 23
      1. Popularity of Over-the-Counter
    8. (OTC) Drugs 23
      1. Restraints 23
      2. High Cost of Diagnostics and Surgeries
      3. Stringent Government Regulations 23
      4. Opportunities 24
    9. Entering Untapped Markets 24
    10. Market Factor Analysis
      1. Value Chain
    11. Analysis 25
      1. R&D and Product Development 25
        1. Manufacturing
        2. Distribution & Sales 26
        3. Post-Sales Monitoring 26
      2. Porter’s Five Forces Analysis 27
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers 28
        3. Threat of New Entrants 28
        4. Threat of Substitutes 28
        5. Intensity of Rivalry 28
      3. Investment
    12. Opportunity Analysis 29
    13. Global Carotid Artery Disease Market by Treatment
    14. & Diagnosis
      1. Introduction 30
      2. Treatment 33
      3. Diagnosis
    15. Global Carotid Artery Disease Market by End User
      1. Introduction
      2. Hospital & Clinics 36
      3. Ambulatory Surgical Centers 37
      4. Pharmacies 37
    16. Global Carotid Artery Disease Market by Region
    17. Introduction 38
      1. Americas 39
        1. North America 43
        2. South America 51
      2. Europe 54
    18. Western Europe 57
      1. Germany 60
        1. UK 62
        2. Eastern Europe 75
      2. Asia-Pacific 78
        1. Japan 81
        2. China 83
        3. India 86
        4. Australia 88
        5. South Korea
        6. Rest of Asia-Pacific 93
      3. Middle East & Africa 96
    19. Middle East 99
      1. Africa 102
    20. Competitive Landscape
      1. Introduction
      2. Key developments 106
    21. Company Profiles
      1. W. L. Gore
    22. & Associates, Inc. 109
      1. Company Overview 109
        1. Financial
    23. Overview 109
      1. Products/Services Offered 109
        1. Key Developments
        2. SWOT Analysis 110
        3. Key Strategies 110
      2. Becton,
    24. Dickinson and Company 111
      1. Company Overview 111
        1. Financial
    25. Overview 111
      1. Products/Services Offered 111
        1. Key Developments
        2. SWOT Analysis 112
        3. Key Strategies 112
      2. Terumo
    26. Corporation 113
      1. Company Overview 113
        1. Financial Overview
        2. Products/Services Offered 113
        3. Key Developments 114
        4. SWOT Analysis 114
        5. Key Strategies 114
      2. Hitachi, Ltd
        1. Company Overview 115
        2. Financial Overview 115
    27. Products/Services Offered 116
      1. Key Developments 116
        1. SWOT
    28. Analysis 116
      1. Key Strategies 117
      2. Silk Road Medical, Inc. 118
        1. Company Overview 118
        2. Financial Overview 118
        3. Products/Services
    29. Offered 118
      1. Key Developments 118
        1. SWOT Analysis 119
    30. Key Strategies 119
      1. Abbott 120
        1. Company Overview 120
    31. Financial Overview 120
      1. Products/Services Offered 121
        1. Key
    32. Developments 121
      1. SWOT Analysis 121
        1. Key Strategies 121
      2. Medtronic 122
        1. Company Overview 122
        2. Financial Overview
        3. Products/Services Offered 123
        4. Key Developments 123
        5. SWOT Analysis 123
        6. Key Strategies 123
      3. Stryker Corporation
        1. Company Overview 124
        2. Financial Overview 124
    33. Products/Services Offered 125
      1. Key Developments 125
        1. SWOT
    34. Analysis 125
      1. Key Strategies 125
      2. Cardinal Health 126
    35. Company Overview 126
      1. Financial Overview 126
        1. Products/Services
    36. Offered 127
      1. Key Developments 127
        1. SWOT Analysis 127
    37. Key Strategies 127
      1. Boston Scientific Corporation 128
        1. Company
    38. Overview 128
      1. Financial Overview 128
        1. Products/Services
    39. Offered 129
      1. Key Developments 129
        1. SWOT Analysis 129
        2. Key Strategies 129
    40. Appendix
      1. References 130
    41. Related Reports 130
    42. List of Tables
    43. BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 30
    44. CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 31
    45. GLOBAL CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION)
    46. TO 2027 (USD MILLION) 32
    47. TREATMENT, BY REGION, 2020 TO 2027 (USD MILLION) 32
    48. ARTERY DISEASE MARKET, FOR DIAGNOSIS, BY REGION, 2020 TO 2027 (USD MILLION) 33
    49. BY REGION, 2020 TO 2027 (USD MILLION) 35
    50. MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION,
    51. TO 2027 (USD MILLION)
    52. TO 2027 (USD MILLION) 36
    53. BY REGION, 2020 TO 2027 (USD MILLION) 37
    54. DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 38
    55. CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 39
    56. AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO
    57. (USD MILLION) 39
    58. TREATMENT, 2020 TO 2027 (USD MILLION) 39
    59. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 40
    60. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    61. (USD MILLION) 41
    62. REGION, 2020 TO 2027 (USD MILLION) 41
    63. DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 42
    64. NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD
    65. MILLION) 42
    66. TO 2027 (USD MILLION) 43
    67. MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 43
    68. AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION)
    69. TO 2027 (USD MILLION) 44
    70. TREATMENT, 2020 TO 2027 (USD MILLION) 45
    71. MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 45
    72. DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 46
    73. US: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 46
    74. TO 2027 (USD MILLION) 47
    75. BY TREATMENT, 2020 TO 2027 (USD MILLION) 47
    76. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 48
    77. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    78. (USD MILLION) 49
    79. TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 49
    80. CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 50
    81. SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD
    82. MILLION) 50
    83. PROCEDURE, 2020 TO 2027 (USD MILLION) 51
    84. DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 51
    85. CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 52
    86. EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES)
    87. TO 2027 (USD MILLION) 53
    88. BY TREATMENT, 2020 TO 2027 (USD MILLION) 53
    89. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 53
    90. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    91. (USD MILLION) 54
    92. REGION, 2020 TO 2027 (USD MILLION) 55
    93. DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 56
    94. WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD
    95. MILLION) 56
    96. TO 2027 (USD MILLION) 56
    97. MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 57
    98. EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 57
    99. TO 2027 (USD MILLION) 58
    100. BY TREATMENT, 2020 TO 2027 (USD MILLION) 58
    101. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 59
    102. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    103. (USD MILLION) 60
    104. DIAGNOSIS, 2020 TO 2027 (USD MILLION) 60
    105. MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 61
    106. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 61
    107. ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 62
    108. UK: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 62
    109. TO 2027 (USD MILLION) 63
    110. BY TREATMENT, 2020 TO 2027 (USD MILLION) 63
    111. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 64
    112. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    113. (USD MILLION) 65
    114. & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 65
    115. DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 66
    116. CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 66
    117. ITALY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD
    118. MILLION) 67
    119. TO 2027 (USD MILLION) 67
    120. TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 68
    121. ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 68
    122. SPAIN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION)
    123. TO 2027 (USD MILLION) 69
    124. END USER, 2020 TO 2027 (USD MILLION) 70
    125. ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS,
    126. TO 2027 (USD MILLION)
    127. TO 2027 (USD MILLION) 71
    128. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 71
    129. OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO
    130. (USD MILLION) 72
    131. MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 72
    132. CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
    133. TO 2027 (USD MILLION) 73
    134. BY MEDICATION, 2020 TO 2027 (USD MILLION) 74
    135. ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 74
    136. EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD
    137. MILLION) 75
    138. TO 2027 (USD MILLION) 76
    139. MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 76
    140. ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
    141. TO 2027 (USD MILLION) 77
    142. BY MEDICATION, 2020 TO 2027 (USD MILLION) 77
    143. ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 77
    144. ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION)
    145. TO 2027 (USD MILLION) 79
    146. BY TREATMENT, 2020 TO 2027 (USD MILLION) 79
    147. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 80
    148. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    149. (USD MILLION) 81
    150. & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 81
    151. DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 82
    152. CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 82
    153. CHINA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD
    154. MILLION) 83
    155. TO 2027 (USD MILLION) 83
    156. TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 84
    157. ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 84
    158. INDIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION)
    159. TO 2027 (USD MILLION) 85
    160. END USER, 2020 TO 2027 (USD MILLION) 86
    161. DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 86
    162. AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION)
    163. TO 2027 (USD MILLION) 87
    164. BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 88
    165. ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 88
    166. SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO
    167. (USD MILLION) 89
    168. BY TREATMENT, 2020 TO 2027 (USD MILLION) 89
    169. ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 90
    170. SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027
    171. (USD MILLION) 90
    172. USER, 2020 TO 2027 (USD MILLION) 91
    173. ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
    174. TO 2027 (USD MILLION) 92
    175. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 92
    176. OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027
    177. (USD MILLION) 93
    178. BY END USER, 2020 TO 2027 (USD MILLION) 93
    179. CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 94
    180. MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO
    181. (PROCEDURE) 94
    182. MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 95
    183. MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027
    184. (USD MILLION) 95
    185. MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 96
    186. & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027
    187. (USD MILLION) 96
    188. MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 97
    189. ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION)
    190. TO 2027 (USD MILLION) 98
    191. BY MEDICATION, 2020 TO 2027 (USD MILLION) 98
    192. ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 99
    193. MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION)
    194. TO 2027 (USD MILLION) 100
    195. BY TREATMENT, 2020 TO 2027 (USD MILLION) 100
    196. DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 101
    197. CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION)
    198. (USD MILLION) 102
    199. DISEASE MARKET 103
    200. List of Figures
    201. ARTERY DISEASE MARKET: STRUCTURE 16
    202. TOP-DOWN AND BOTTOM-UP APPROACHES 20
    203. THE CAROTID ARTERY DISEASE MARKET 21
    204. CAROTID ARTERY DISEASE MARKET 24
    205. GLOBAL CAROTID ARTERY DISEASE MARKET 26
    206. MARKET, BY TREATMENT & DIAGNOSIS, 2020 & 2027 (USD MILLION) 30
    207. GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 & 2027 (USD MILLION)
    208. BY REGION, 2020 (%) 55
    209. SHARE, BY REGION, 2020 (%) 76
    210. DISEASE MARKET SHARE, BY REGION, 2020 (%) 94
    211. OF KEY DEVELOPMENTS 106'

    Carotid Artery Disease Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Carotid Artery Disease Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials